黑料网

Breast cancer; Stages; Diagnosis; Tumor size; Lymph node involvement; Metastasis; treatment; Prognosis; Staging system

Breast cancer is a malignant tumor that originates in the cells of the breast, most commonly in the ducts or lobules. While breast cancer is more common in women [1], it can also affect men. Over the years, advances in medical research, early detection, and treatment options have significantly improved survival rates for breast cancer patients. One of the fundamental aspects of managing breast cancer is understanding its stage. Staging refers to the extent of cancer spread in the body, and it plays a pivotal role in deciding the appropriate treatment plan. This article will provide an in-depth examination of breast cancer stages [2], factors that determine them, and their clinical relevance.

Understanding the Staging System

Breast cancer staging is primarily determined using the TNM system, a classification system developed by the American Joint Committee on Cancer (AJCC). The TNM system considers three main factors:

T (Tumor): Refers to the size and extent of the primary tumor [3].

N (Nodes): Describes whether the cancer has spread to nearby lymph nodes.

M (Metastasis): Indicates whether the cancer has spread to other parts of the body.

Each of these categories is assigned a number or letter to indicate the extent of involvement. The final stage of cancer is expressed as a combination of these elements, ranging from stage 0 (localized) to stage IV (advanced/metastatic) [4].

Stage 0: Ductal Carcinoma in Situ (DCIS)

Stage 0 represents the earliest form of breast cancer and is often referred to as "in situ" cancer, meaning the tumor is confined to its place of origin. The most common form of stage 0 breast cancer is ductal carcinoma in situ (DCIS), which involves abnormal cells that are confined to the milk ducts but have not spread to surrounding tissues. While not yet invasive, DCIS is considered a precursor to invasive breast cancer, and it can increase the risk of developing more aggressive forms of cancer in the future [5].

Treatment for stage 0 often involves surgery to remove the abnormal tissue, sometimes followed by radiation therapy or hormone therapy, depending on individual factors such as the patient's age and hormone receptor status.

Stage I: Early Invasive Cancer

In stage I, the cancer is invasive but still localized within the breast. The tumor is relatively small, measuring up to 2 centimeters in size. The cancer cells may have started to invade surrounding tissues but have not spread to the lymph nodes or distant organs [6].

Stage I is divided into two subcategories:

Stage IA: The tumor is 2 cm or smaller and has not spread to the lymph nodes.

Stage IB: There is no detectable tumor in the breast, but small clusters of cancer cells are found in the lymph nodes.

Stage I breast cancer is typically treated with surgery (either lumpectomy or mastectomy), followed by radiation therapy. In some cases, chemotherapy or hormone therapy may be recommended depending on the cancer's receptor status and grade [7].

Stage II: Localized Cancer

Stage II breast cancer is more advanced than stage I but still confined to the breast or nearby lymph nodes. It is divided into two subcategories:

Stage IIA:

The tumor is 2 cm or smaller but has spread to the nearby lymph nodes, or

The tumor is between 2 and 5 cm but has not spread to the lymph nodes.

Stage IIB:

The tumor is between 2 and 5 cm and has spread to nearby lymph nodes, or

The tumor is larger than 5 cm but has not spread to the lymph nodes.

Treatment for stage II typically involves a combination of surgery (lumpectomy or mastectomy), radiation therapy, chemotherapy, and sometimes hormone therapy or targeted therapy, depending on the molecular characteristics of the tumor.

Stage III: Locally Advanced Cancer

Stage III breast cancer is considered locally advanced, meaning that the cancer has spread beyond the breast tissue to nearby lymph nodes and possibly to the chest wall or skin but has not yet spread to distant parts of the body. There are three subcategories:

Stage IIIA: The tumor is larger than 5 cm and has spread to the lymph nodes, or the cancer has spread to nearby lymph nodes but not to the chest wall or skin.

Stage IIIB: The tumor has spread to the chest wall or skin but has not spread to distant organs. It may also involve lymph nodes.

Stage IIIC: The cancer has spread to lymph nodes located above or below the collarbone or to lymph nodes that are connected to the chest wall, but there is no distant metastasis.

Treatment for stage III breast cancer often involves a combination of chemotherapy (sometimes before surgery, called neoadjuvant chemotherapy), surgery, radiation, and targeted therapies. Hormone therapy may also be recommended if the cancer is hormone receptor-positive.

Stage IV: Metastatic Cancer

Stage IV breast cancer, also known as metastatic breast cancer, is the most advanced form of the disease. At this stage, the cancer has spread to distant organs such as the liver, lungs, bones, or brain. The primary tumor may still be present in the breast, but the focus of treatment is on managing the cancer that has spread to other parts of the body.

Treatment for stage IV breast cancer aims to control the spread of the disease, relieve symptoms, and prolong survival. Options include chemotherapy, hormone therapy, targeted therapies, immunotherapy, and palliative care to manage symptoms. Although stage IV breast cancer is not considered curable, advances in treatment have improved survival rates and quality of life for many patients.

Factors Influencing Treatment Based on Staging

The stage of breast cancer plays a critical role in determining the treatment approach. Early-stage cancers (stage 0 to II) are often treatable with localized therapies such as surgery and radiation. For later stages (stage III and IV), systemic treatments like chemotherapy, hormone therapy, and targeted therapies are necessary to address cancer that has spread beyond the breast. The molecular subtype of the tumor also significantly influences treatment decisions. For example, hormone receptor-positive cancers are treated with hormone therapies like tamoxifen or aromatase inhibitors. HER2-positive cancers may be treated with targeted therapies like trastuzumab (Herceptin), while triple-negative breast cancer, which lacks estrogen, progesterone, and HER2 receptors, often requires chemotherapy.

Conclusion

Breast cancer staging is a fundamental aspect of understanding the disease and determining the best course of treatment. The stages range from localized, early-stage tumors (stage 0 to II) to advanced, metastatic cancers (stage III and IV), each with distinct characteristics and treatment requirements. Early detection and advances in personalized medicine have made it possible for patients to receive more effective, tailored treatments, improving survival rates and quality of life. The continuous improvement in staging and treatment modalities holds promise for even better outcomes in the future.

1. Wu X, Zhou H, He Z (2020) . Transl Lung Cancer Res 9: 2494-2499.

, ,

2. Wang R, Qin J, Fan Y (2020) . Onco Targets Ther 13: 4183-4187.

, ,

3. Wu X, Wang W, Zou B (2020) . Thorac Cancer 11: 1695-1698.

, ,

4. Jin L, Wang Y, Li S (2020) . Lung Cancer 146: 382-384.

, ,

5. Zhang J, Zou C, Zhou C (2020) . J Thorac Oncol 15: 1073-1077.

, ,

6. Ma L, Zhang Q, Dong Y (2020) . Lung Cancer 143: 97-100.

, ,

7. Cai C, Long Y, Li Y (2020) . Onco Targets Ther 13: 8313-8316.

, ,